INTERNATIONAL PATENT: REGENERON PHARMACEUTICALS, INC. FILES APPLICATION FOR "TUMOR-TARGETED IL2 RECEPTOR AGONISTS AND MULTISPECIFIC T-CELL ENGAGERS"

GENEVA, April 14 -- REGENERON PHARMACEUTICALS, INC. (777 Old Saw Mill River RoadTarrytown, New York 10591) filed a patent application (PCT/US2025/048787) for "TUMOR-TARGETED IL2 RECEPTOR AGONISTS AND MULTISPECIFIC T-CELL ENGAGERS" on Sep 30, 2025. With publication no. WO/2026/076013, the details related to the patent application was published on Apr 09, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): PATEL, Supriya (c/o Regeneron Pharmaceuticals, Inc.,777 Old Saw Mill River RoadTarrytown, New York 10591), CRAWFORD, Alison (c/o Regeneron Pharmaceuticals, Inc.,777 Old Saw Mill River RoadTarryt...